Search
for
Did you mean JAK1/2 inhibitor?
Research 10 of 790
- JAK inhibitors in dermatology: The promise of a new drug class
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Under Development JAK Inhibitors for Dermatologic Diseases
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- JAK Inhibitors for Treatment of Alopecia Areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →